tyrosyl-arginyl-phenylalanyl-lysinamide has been researched along with aconitine in 1 studies
| Studies (tyrosyl-arginyl-phenylalanyl-lysinamide) | Trials (tyrosyl-arginyl-phenylalanyl-lysinamide) | Recent Studies (post-2010) (tyrosyl-arginyl-phenylalanyl-lysinamide) | Studies (aconitine) | Trials (aconitine) | Recent Studies (post-2010) (aconitine) |
|---|---|---|---|---|---|
| 74 | 0 | 17 | 1,609 | 21 | 497 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Krylatov, AV; Lishmanov, YB; Maslov, LN; Solenkova, NV; Stakheev, DL | 1 |
1 other study(ies) available for tyrosyl-arginyl-phenylalanyl-lysinamide and aconitine
| Article | Year |
|---|---|
Possible mechanism underlying the antiarrhythmic effect of peptides nociceptin and DALDA on the heart.
Topics: Aconitine; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrocardiography; Glyburide; Indomethacin; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nociceptin; Oligopeptides; Opioid Peptides; Potassium Channels; Rats; Rats, Wistar | 2003 |